Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)

指紋

深入研究「Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk」主題。共同形成了獨特的指紋。

Medicine & Life Sciences